Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian Cancer

Emil Lou,Valentino Clemente,Marcel Grube,Axel Svedbom,Andrew C. Nelson,Freya Blome,Annette Staebler,Stefan Kommoss,Martina Bazzaro

DOI: https://doi.org/10.1001/jamanetworkopen.2024.0407

2024-02-28

JAMA Network Open

Abstract:This prognostic study examines the utility of tumor-stroma proportion as a predictive biomarker for chemoresistance among patients with ovarian cancer.

medicine, general & internal